Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics (PK)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
Co-Hosted with GE Healthcare
The assessment of unwanted immunogenicity is a key parameter in the development process of biological protein drugs. In this webinar, BioAgilytix’s experts Dr. Arno Kromminga and Dr. Daniel Worms discuss aspects of when and how to use the Biacore™ T200 SPR System to obtain a deeper understanding of unwanted immunogenicity.
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
LinkedIn Company Updates
Today Agoview on linkedin
This Friday 28 June in Munich, Germany, Dr. Arno Kromminga & Dr. Lydia Michaut will be hosting a workshop on new aspects in regulated bioanalysis. Email soubhik.banerjee@bioagilytix.de to reserve your spot and view the full agenda here: https://lnkd.in/eZYUiCR
3 Days Agoview on linkedin
It’s easy to fall behind on the ever-shifting trends in bioanalysis, but with BioAgilytix’s newsletter, you can stay up to date on the industry and our own team’s developments. Subscribe to “The Dose” today: https://lnkd.in/eC4NwPB
June 20, 2019BioAgilytix Team Q&A: Meet Mike Losauro, Senior Business Development Director at BioAgilytix
June 14, 2019Your Questions About Immunogenicity Assessment of Gene Therapy Compounds Answered
June 11, 2019BioAgilytix Welcomes Sean Blake to Leadership Team as Chief Information Officer
March 26, 2019BioAgilytix Announces Promotion of Corinna Fiorotti, Ph.D. to Scientific Officer and Key Accounts Director
May 9, 2018Evaluating the Immunogenicity of Antibody–drug Conjugates
April 16, 2018Strategies for Development and Validation of Neutralizing Antibody Assays Supporting Biosimilars
Services
Platforms
Choose a Location to learn more about the premier bioanalytical services and solutions available at each of our advanced laboratories in the USA and Europe.
